SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes [Cardiovascular disease]
Annals of Family Medicine
NOVEMBER 20, 2024
Context Two thirds of diabetes patients complicated with hypertension, and comorbidity increase 4-fold risk of atherosclerotic cardiovascular disease (ASCVD). Study design and analysis This is a multiple-center retrospective real-world cohort study. Setting or Dataset Five electronic systems of community clinic.
130 
Let's personalize your content